Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mercaptoimidazoles as CCR2 receptor antagonists

Mercaptoimidazoles as CCR2 receptor antagonists

US Patent 7511068 · Granted Mar 31, 2009

Estimated economic value: $72,969,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted indoline derivatives as dengue viral replication inhibitors2023
Substituted indoline derivatives as dengue viral replication inhibitors2023
Amide derivatives useful in the treatment of HBV infection or HBV-induced diseas2022
Substituted indoline derivatives as dengue viral replication inhibitors2022
Substituted indoline derivatives as dengue viral replication inhibitors2021
Substituted indoline derivatives as dengue viral replication inhibitors2021
Dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the tre2020
6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile deriva2019
Piperidine/piperazine derivatives2017
Piperidine/piperazine derivatives2016
Piperidine/piperazine derivatives2016
Piperidine/piperazine derivatives2016